EOS imaging received approval from the China Food and Drug Administration to market the EOS system.
Here are three things to know:
1. The EOS system is already in clinical use in several markets in the Asia-Pacific region, including Hong Kong, Singapore, Japan, Australia and Vietnam.
2. With this new approval, the EOS system can be marketed in 51 countries worldwide.
3. The EOS system is a medical imaging system focused on osteoarticular pathologies and orthopedics.